{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T23:04:51Z","timestamp":1768431891371,"version":"3.49.0"},"reference-count":45,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2006,3,1]],"date-time":"2006-03-01T00:00:00Z","timestamp":1141171200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuroscience"],"published-print":{"date-parts":[[2006,3]]},"DOI":"10.1016\/j.neuroscience.2005.07.007","type":"journal-article","created":{"date-parts":[[2005,11,29]],"date-time":"2005-11-29T12:45:31Z","timestamp":1133268331000},"page":"1041-1048","source":"Crossref","is-referenced-by-count":41,"title":["Neuroactive steroids as modulators of depression and anxiety"],"prefix":"10.1016","volume":"138","author":[{"given":"D.","family":"Eser","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Romeo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.C.","family":"Baghai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"di Michele","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Sch\u00fcle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Pasini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Zwanzger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Padberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Rupprecht","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuroscience.2005.07.007_bib1","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1038\/sj.npp.1300684","article-title":"Plasma concentrations of neuroactive steroids before and after electroconvulsive therapy","volume":"30","author":"Baghai","year":"2005","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuroscience.2005.07.007_bib2","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/S0306-4530(00)00017-2","article-title":"Plasma 5\u03b1-androstane-3\u03b1, 17\u03b2diol, an endogenous steroid that positively modulates GABAA receptor function, and anxiety","volume":"25","author":"Barbaccia","year":"2000","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.neuroscience.2005.07.007_bib3","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/S0022-3565(24)37308-2","article-title":"Reversal of behavioural effects of pentylenetetrazol by the neuroactive steroid ganaxolone","volume":"284","author":"Beekman","year":"1998","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.neuroscience.2005.07.007_bib4","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1023\/A:1026622704704","article-title":"Serum concentrations of some neuroactive steroids in women suffering from mixed anxiety-depressive disorder","volume":"25","author":"Bicikova","year":"2000","journal-title":"Neurochem Res"},{"key":"10.1016\/j.neuroscience.2005.07.007_bib5","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/0006-8993(91)90761-J","article-title":"Anxiolytic effects of 3\u03b1-hydroxy-5\u03b1[\u03b2]-pregnan-20-one","volume":"561","author":"Bitran","year":"1991","journal-title":"Brain Res"},{"key":"10.1016\/j.neuroscience.2005.07.007_bib6","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1365-2826.1995.tb00744.x","article-title":"Anxiolytic effect of progesterone is mediated by the neurosteroid allopregnanolone at brain GABAA receptors","volume":"7","author":"Bitran","year":"1995","journal-title":"J Neuroendocrinol"},{"key":"10.1016\/j.neuroscience.2005.07.007_bib7","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0165-1781(03)00077-5","article-title":"Neurosteroid secretion in panic disorder","volume":"118","author":"Brambilla","year":"2003","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.neuroscience.2005.07.007_bib8","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/0006-8993(86)91500-3","article-title":"Anxiolytic activity of an endogenous adrenal steroid","volume":"398","author":"Crawley","year":"1986","journal-title":"Brain Res"},{"key":"10.1016\/j.neuroscience.2005.07.007_bib9","doi-asserted-by":"crossref","first-page":"2849","DOI":"10.1073\/pnas.051628598","article-title":"Brain 5\u03b1-dihydroprogesterone and allopregnanolone synthesis in a mouse model of protracted social isolation","volume":"98","author":"Dong","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.neuroscience.2005.07.007_bib10","first-page":"420","article-title":"CCD-3693","volume":"282","author":"Edgar","year":"1997","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.neuroscience.2005.07.007_bib11","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/sj.npp.1300572","article-title":"Panic induction with cholecystokinin-tetrapeptide (CCK-4) increases plasma concentrations of the neuroactive steroid 3\u03b1, 5\u03b1-tetrahydrodeoxycorticosterone (3\u03b1, 5\u03b1-THDOC) in healthy volunteers","volume":"30","author":"Eser","year":"2005","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuroscience.2005.07.007_bib12","doi-asserted-by":"crossref","first-page":"13512","DOI":"10.1073\/pnas.96.23.13512","article-title":"Selective serotonin reuptake inhibitors directly alter activity of neurosteroidogenic enzymes","volume":"96","author":"Griffin","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.neuroscience.2005.07.007_bib13","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1017\/S0033291702005238","article-title":"Low pregnenolone sulphate plasma concentrations in patients with generalized social phobia","volume":"32","author":"Heydari","year":"2002","journal-title":"Psychol Med"},{"key":"10.1016\/j.neuroscience.2005.07.007_bib14","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0091-3057(00)00300-2","article-title":"Antidepressant-like effect of the neurosteroid 3\u03b1-hydroxy-5\u03b1-pregnan-20-one in mice forced swim test","volume":"67","author":"Khisti","year":"2000","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.neuroscience.2005.07.007_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/(SICI)1520-6394(1998)8:1<1::AID-DA1>3.0.CO;2-G","article-title":"Behavioral, cardiovascular, and neuroendocrine profiles following CCK-4 challenge in healthy volunteers","volume":"8","author":"Koszycki","year":"1998","journal-title":"Depress Anxiety"},{"key":"10.1016\/j.neuroscience.2005.07.007_bib16","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0165-6147(00)89058-6","article-title":"Neurosteroids and GABAA receptor function","volume":"16","author":"Lambert","year":"1995","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.neuroscience.2005.07.007_bib17","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0006-8993(03)02939-1","article-title":"Allopregnanolone-stimulated GABA-mediated chloride ion flux is inhibited by 3\u03b2-hydroxy-5\u03b1-pregnan-20-one (isoallopregnanolone)","volume":"982","author":"Lundgren","year":"2003","journal-title":"Brain Res"},{"key":"10.1016\/j.neuroscience.2005.07.007_bib18","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1139\/y98-091","article-title":"Modulation of GABAA receptor function by neuroactive steroids","volume":"76","author":"Maitra","year":"1998","journal-title":"Can J Physiol Pharmacol"},{"key":"10.1016\/j.neuroscience.2005.07.007_bib19","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1126\/science.2422758","article-title":"Steroid hormone metabolites are barbiturate-like modulators of the GABA receptor","volume":"232","author":"Majewska","year":"1986","journal-title":"Science"},{"key":"10.1016\/j.neuroscience.2005.07.007_bib20","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/S0893-133X(02)00355-X","article-title":"Plasma concentrations of neuroactive steroids before and after repetitive transcranial magnetic stimulation (rTMS) in major depression","volume":"27","author":"Padberg","year":"2002","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuroscience.2005.07.007_bib21","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S0893-133X(96)00096-6","article-title":"The neurosteroid tetrahydroprogesterone attenuates the endocrine response to stress and exerts glucocorticoid-like effects on vasopressin gene transcription in the rat hypothalamus","volume":"15","author":"Patchev","year":"1996","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuroscience.2005.07.007_bib22","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1096\/fasebj.6.6.1347506","article-title":"Neuroactive steroids","volume":"6","author":"Paul","year":"1992","journal-title":"FASEB J"},{"key":"10.1016\/j.neuroscience.2005.07.007_bib23","doi-asserted-by":"crossref","first-page":"4553","DOI":"10.1073\/pnas.88.10.4553","article-title":"Stress-induced elevations of \u03b3-aminobutyric acid type A receptor-active steroids in the rat brain","volume":"8","author":"Purdy","year":"1991","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.neuroscience.2005.07.007_bib24","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0165-6147(03)00023-3","article-title":"Is there a physiological role for the neurosteroid THDOC in stress-sensitive conditions","volume":"24","author":"Reddy","year":"2003","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.neuroscience.2005.07.007_bib25","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.neuropharm.2004.09.002","article-title":"Anxiolytic activity of progesterone in progesterone receptor knockout mice","volume":"48","author":"Reddy","year":"2005","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuroscience.2005.07.007_bib26","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0091-3057(97)00339-0","article-title":"Behaviorally selective effects of neuroactive steroids on plus-maze anxiety in mice","volume":"59","author":"Rodgers","year":"1998","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.neuroscience.2005.07.007_bib27","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1176\/ajp.155.7.910","article-title":"Effects of antidepressant treatment on neuroactive steroids in major depression","volume":"155","author":"Romeo","year":"1998","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.neuroscience.2005.07.007_bib28","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0306-4530(02)00064-1","article-title":"Neuroactive steroids","volume":"28","author":"Rupprecht","year":"2003","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.neuroscience.2005.07.007_bib29","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/sj.npp.1300084","article-title":"Influence of sleep deprivation on neuroactive steroids in major depression","volume":"28","author":"Sch\u00fcle","year":"2003","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuroscience.2005.07.007_bib30","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1176\/appi.neuropsych.13.3.396","article-title":"Neuroactive steroid levels in patients with generalized anxiety disorder","volume":"13","author":"Semeniuk","year":"2001","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"10.1016\/j.neuroscience.2005.07.007_bib31","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1007\/s002130100853","article-title":"Opposite effects of short- versus long-term administration of fluoxetine on the concentrations of neuroactive steroids in rat plasma and brain","volume":"158","author":"Serra","year":"2001","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuroscience.2005.07.007_bib32","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0006-3223(98)00328-X","article-title":"Concentrations of 3\u03b1-reduced neuroactive steroids and their precursors in plasma of patients with major depression and after clinical recovery","volume":"45","author":"Str\u00f6hle","year":"1999","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.neuroscience.2005.07.007_bib33","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0022-3956(00)00006-6","article-title":"Fluoxetine decreases concentrations of 3\u03b1, 5\u03b1-tetrahydrodeoxycorticosterone (THDOC) in major depression","volume":"34","author":"Str\u00f6hle","year":"2000","journal-title":"J Psychiatr Res"},{"key":"10.1016\/j.neuroscience.2005.07.007_bib34","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1176\/appi.ajp.159.1.145","article-title":"GABAA receptor modulatory neuroactive steroid composition in panic disorder and during paroxetine treatment","volume":"159","author":"Str\u00f6hle","year":"2002","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.neuroscience.2005.07.007_bib35","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1001\/archpsyc.60.2.161","article-title":"Induced panic attacks shift \u03b3-aminobutyric acid type A receptor modulatory neuroactive steroid composition in patients with panic disorder","volume":"60","author":"Str\u00f6hle","year":"2003","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.neuroscience.2005.07.007_bib36","doi-asserted-by":"crossref","first-page":"13451","DOI":"10.1021\/bi026109w","article-title":"Kinetics of allopregnanolone formation catalyzed by human 3\u03b1-hydroxysteroid dehydrogenase type III (AKR1C2)","volume":"41","author":"Trauger","year":"2002","journal-title":"Biochemistry"},{"key":"10.1016\/j.neuroscience.2005.07.007_bib37","doi-asserted-by":"crossref","first-page":"12599","DOI":"10.1073\/pnas.93.22.12599","article-title":"Fluoxetine-elicited changes in brain neurosteroid content measured by negative ion mass fragmentography","volume":"93","author":"Uzunov","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.neuroscience.2005.07.007_bib38","doi-asserted-by":"crossref","first-page":"3239","DOI":"10.1073\/pnas.95.6.3239","article-title":"Increase in the cerebrospinal fluid content of neurosteroids in patients with unipolar major depression who are receiving fluoxetine or fluvoxamine","volume":"95","author":"Uzunova","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.neuroscience.2005.07.007_bib39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0006-8993(03)02577-0","article-title":"Region-specific dysregulation of allopregnanolone brain content in the olfactory-bulbectomized rat model of depression","volume":"976","author":"Uzunova","year":"2003","journal-title":"Brain Res"},{"key":"10.1016\/j.neuroscience.2005.07.007_bib40","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.ejphar.2003.12.002","article-title":"Chronic antidepressants reverse cerebrocortical allopregnanolone decline in the olfactory-bulbectomized rat","volume":"486","author":"Uzunova","year":"2004","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.neuroscience.2005.07.007_bib41","first-page":"337","article-title":"Characterization of the anxiolytic properties of a novel neuroactive steroid, Co 2-6749 (GMA-839; WAY-141839; 3\u03b1, 21-dihydroxy-3\u03b2-trifluoromethyl-19-nor-5\u03b2-pregnan-20-one), a selective modulator of \u03b3-aminobutyric acidA receptors","volume":"295","author":"Vanover","year":"2000","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.neuroscience.2005.07.007_bib42","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/0006-8993(91)91658-N","article-title":"Anxiolytic activity of the progesterone metabolite 5\u03b1-pregnan-3\u03b1-ol-20-one","volume":"565","author":"Wieland","year":"1991","journal-title":"Brain Res"},{"key":"10.1016\/j.neuroscience.2005.07.007_bib43","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/BF02245251","article-title":"Comparative behavioral characterization of the neuroactive steroids 3\u03b1-OH,5\u03b1-pregnan-20-one and 3\u03b1-OH,5\u03b2-pregnan-20-one in rodents","volume":"118","author":"Wieland","year":"1995","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuroscience.2005.07.007_bib44","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1007\/s002130050424","article-title":"Anxiolytic and anticonvulsant activity of a synthetic neuroactive steroid Co 3-0593","volume":"134","author":"Wieland","year":"1997","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuroscience.2005.07.007_bib45","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0022-3956(03)00109-2","article-title":"Neuroactive steroids are not affected by panic induction with 50 \u03bcg cholecystokinin-tetrapeptide (CCK-4) in healthy volunteers","volume":"38","author":"Zwanzger","year":"2004","journal-title":"J Psychiatr Res"}],"container-title":["Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452205007487?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452205007487?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,5]],"date-time":"2025-01-05T23:56:43Z","timestamp":1736121403000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306452205007487"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,3]]},"references-count":45,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2006,3]]}},"alternative-id":["S0306452205007487"],"URL":"https:\/\/doi.org\/10.1016\/j.neuroscience.2005.07.007","relation":{},"ISSN":["0306-4522"],"issn-type":[{"value":"0306-4522","type":"print"}],"subject":[],"published":{"date-parts":[[2006,3]]}}}